ASHLEY TROOD: Open Payments
NPI 1285379164 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,608 in 188 payments from 24 companies in 2025. Trend: 2023 $2,035 · 2024 $2,076 · 2025 $2,608
Food & beverage: $2,608
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 19 | $274 |
| Insulet Corporation | 42 | $272 |
| Amgen Inc. | 19 | $265 |
| Novo Nordisk Inc | 15 | $236 |
| Lilly USA, LLC | 9 | $207 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $177 |
| Corcept Therapeutics | 12 | $172 |
| Neurocrine BioSciences, Inc. | 14 | $162 |
| Dexcom, Inc. | 9 | $135 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $82 |
Products named: Omnipod, Kerendia, Korlym, CRENESSITY, MOUNJARO, EVENITY, GVOKE HYPOPEN, Dexcom G6 Transmitter.
Industry payments across KS — which companies pay providers there.
